|
1
|
Wilson WR and Hay MP: Targeting hypoxia in
cancer therapy. Nat Rev Cancer. 11:393–410. 2011. View Article : Google Scholar
|
|
2
|
Nordsmark M, Bentzen SM, Rudat V, et al:
Prognostic value of tumor oxygenation in 397 head and neck tumors
after primary radiation therapy. An international multi-center
study. Radiother Oncol. 77:18–24. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brizel DM, Scully SP, Harrelson JM, et al:
Tumor oxygenation predicts for the likelihood of distant metastases
in human soft tissue sarcoma. Cancer Res. 56:941–943.
1996.PubMed/NCBI
|
|
4
|
Rampling R, Cruickshank G, Lewis AD,
Fitzsimmons SA and Workman P: Direct measurement of pO2
distribution and bioreductive enzymes in human malignant brain
tumors. Int J Radiat Oncol Biol Phys. 29:427–431. 1994.PubMed/NCBI
|
|
5
|
Keith B, Johnson RS and Simon MC: HIF1α
and HIF2α: sibling rivalry in hypoxic tumour growth and
progression. Nat Rev Cancer. 12:9–22. 2012.
|
|
6
|
Wang GL and Semenza GL: General
involvement of hypoxia-inducible factor 1 in transcriptional
response to hypoxia. Proc Natl Acad Sci USA. 90:4304–4308. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Marignol L, Lawler M, Coffey M and
Hollywood D: Achieving hypoxia-inducible gene expression in tumors.
Cancer Biol Ther. 4:359–364. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Greco O, Marples B, Joiner MC and Scott
SD: How to overcome (and exploit) tumor hypoxia for targeted gene
therapy. J Cell Physiol. 197:312–325. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Marignol L, Foley R, Southgate TD, Coffey
M, Hollywood D and Lawler M: Hypoxia response element-driven
cytosine deaminase/5-fluorocytosine gene therapy system: a highly
effective approach to overcome the dynamics of tumour hypoxia and
enhance the radiosensitivity of prostate cancer cells in
vitro. J Gene Med. 11:169–179. 2009. View Article : Google Scholar
|
|
10
|
Koshikawa N, Takenaga K, Tagawa M and
Sakiyama S: Therapeutic efficacy of the suicide gene driven by the
promoter of vascular endothelial growth factor gene against hypoxic
tumor cells. Cancer Res. 60:2936–2941. 2000.PubMed/NCBI
|
|
11
|
Freytag SO, Stricker H, Pegg J, et al:
Phase I study of replication-competent adenovirus-mediated
double-suicide gene therapy in combination with conventional-dose
three-dimensional conformal radiation therapy for the treatment of
newly diagnosed, intermediate- to high-risk prostate cancer. Cancer
Res. 63:7497–7506. 2003.
|
|
12
|
Rogulski KR, Zhang K, Kolozsvary A, Kim JH
and Freytag SO: Pronounced antitumor effects and tumor
radiosensitization of double suicide gene therapy. Clin Cancer Res.
3:2081–2088. 1997.PubMed/NCBI
|
|
13
|
Xing L, Sun X, Deng X, et al: Expression
of the bifunctional suicide gene CDUPRT increases
radiosensitization and bystander effect of 5-FC in prostate cancer
cells. Radiother Oncol. 92:345–352. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Porosnicu M, Mian A and Barber GN: The
oncolytic effect of recombinant vesicular stomatitis virus is
enhanced by expression of the fusion cytosine deaminase/uracil
phosphoribosyltransferase suicide gene. Cancer Res. 63:8366–8376.
2003.
|
|
15
|
Sun X, Xing L, Deng X, et al: Hypoxia
targeted bifunctional suicide gene expression enhances radiotherapy
in vitro and in vivo. Radiother Oncol. 105:57–63.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xing L, Sun X, Deng X, et al: A triple
suicide gene strategy that improves therapeutic effects and
incorporates multimodality molecular imaging for monitoring gene
functions. Cancer Gene Therapy. 20:358–365. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He F, Deng X, Wen B, et al: Noninvasive
molecular imaging of hypoxia in human xenografts: comparing
hypoxia-induced gene expression with endogenous and exogenous
hypoxia markers. Cancer Res. 68:8597–8606. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Binley K, Askham Z, Martin L, et al:
Hypoxia-mediated tumour targeting. Gene Ther. 10:540–549. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu J, Harada H, Ogura M, Shibata T and
Hiraoka M: Adenovirus-mediated hypoxia-targeting cytosine deaminase
gene therapy enhances radiotherapy in tumour xenografts. Br J
Cancer. 96:1871–1878. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee CH, Wu CL and Shiau AL:
Hypoxia-induced cytosine deaminase gene expression for cancer
therapy. Hum Gene Ther. 18:27–38. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang D, Ruan H, Hu L, et al: Development
of a hypoxia-inducible cytosine deaminase expression vector for
gene-directed prodrug cancer therapy. Cancer Gene Ther. 12:276–283.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen JK, Hu LJ, Wang D, Lamborn KR and
Deen DF: Cytosine deaminase/5-fluorocytosine exposure induces
bystander and radiosensitization effects in hypoxic glioblastoma
cells in vitro. Int J Radiat Oncol Biol Phys. 67:1538–1547.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Freytag SO, Kim JH, Brown SL, Barton K, Lu
M and Chung M: Gene therapy strategies to improve the effectiveness
of cancer radiotherapy. Expert Opin Biol Ther. 4:1757–1770. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hwang HS, Davis TW, Houghton JA and
Kinsella TJ: Radiosensitivity of thymidylate synthase-deficient
human tumor cells is affected by progression through the G1
restriction point into S-phase: implications for fluoropyrimidine
radiosensitization. Cancer Res. 60:92–100. 2000.
|
|
25
|
McMasters RA, Saylors RL, Jones KE,
Hendrix ME, Moyer MP and Drake RR: Lack of bystander killing in
herpes simplex virus thymidine kinase-transduced colon cell lines
due to deficient connexin43 gap junction formation. Hum Gen Ther.
9:2253–2261. 1998. View Article : Google Scholar
|
|
26
|
Shirakawa T, Gardner TA, Ko SC, et al:
Cytotoxicity of adenoviral-mediated cytosine deaminase plus
5-fluorocytosine gene therapy is superior to thymidine kinase plus
acyclovir in a human renal cell carcinoma model. J Urol.
162:949–954. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Khatri A, Zhang B, Doherty E, et al:
Combination of cytosine deaminase with uracil phosphoribosyl
transferase leads to local and distant bystander effects against
RM1 prostate cancer in mice. J Gene Med. 8:1086–1096. 2006.
View Article : Google Scholar : PubMed/NCBI
|
